10
R. S. THOMBAL AND V. H. JADHAV
12H), 2.02 (s, 3H), 2.03 (s, 3H), 2.06 (s, 3H), 2.10 (s, 3H), 2.97 (d, J = 9.4 Hz, 1H),
3.51 (d, J = 9.4 Hz, 1H), 3.63–3.71 (m, 1H), 4.16 (dd, J = 9.4 Hz, 1H), 4.28 (dd, J
= 7.7 and 4.5 Hz, 1H), 4.43 (d, J = 7.7 Hz, 1H), 5.01 (dd, J = 9.4 and 4.8 Hz, 1H),
5.09 (t, J = 9.47 Hz, 1H), 5.21 (t, J = 9.3 Hz, 1H); 13C NMR (CDCl3, 50 MHz) δ
20.6, 20.68, 20.7, 28.0, 33.8, 37.0, 39.2, 61.9, 68.4, 71.2, 71.6, 72.7, 80.9, 101.7, 169.2,
169.4, 170.3, 170.7; HRMS (ESI) m/z [M + Na]+ calcd for C25H36O10Na 519.2206,
found 519.2201.
Undecyl 2,3,4,6-tetra-O-acetyl-β-(D)-glucopyranoside, (Table 3, entry 5)
26
White semisolid; Yield 98%; Rf = 0.6 (EtOAc-Pet ether = 1:2); [α]D –1.41 (c =
1.0, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 0.87 (t, J = 7.1 Hz, 3H), 1.24 (bs, 18H),
1.5–1.59 (m, 2H), 2.0 (s, 3H), 2.2 (s, 3H), 2.4 (s, 3H), 2.8 (s, 3H), 3.43–3.49 (m,
1H), 3.67–3.71 (m, 1H), 3.84–3.89 (m, 1H), 4.11–4.14 (m, 1H), 4.26 (dd, J = 7.8 and
4.6 Hz, 1H), 4.49 (d, J = 7.8, 1H), 4.97 (dd, J = 8, 1.4 Hz, 1H), 5.08 (t, J = 9.7, 9.5 Hz),
5.2 (t, J = 9.5, 9.2 Hz, 1H); 13C NMR (CDCl3, 50 MHz) δ 14.2, 20.5, 22.5, 25.7, 29.2,
29.5, 31.7, 61.8, 68.3, 70.2, 71.2, 71.5, 72.7, 100.7, 169.3, 169.4, 170.3, 170.7; HRMS
(ESI) m/z [M + Na]+ calcd for C25H42O10Na 525.2676, found 525.2670.
(9Z)-9-octadecenyl tetra-O-acetyl-β-(D)-glucopyranoside (Table 3, entry 6)
26
White foam; Yield 92%; Rf = 0.3 (EtOAc-Pet ether = 1:2); [α]D –6.62 (c = 0.5,
1
CHCl3); H NMR (CDCl3, 400 MHz) δ 0.89 (t, J = 8.0 Hz, 1H), 1.26 (bs, 24H),
1.5–1.67 (m, 4H), 2.01 (s, 3H), 2.03 (s, 3H), 2.05 (s, 3H), 2.09 (s, 3H), 3.44–3.5 (m,
1H), 3.67–3.72 (m, 1H), 3.85–3.90 (m, 1H), 4.14 (dd, J = 9.7 and 2.4 Hz, 1H), 4.5
(d, J = 8 Hz, 1H), 4.99 (dd, J = 7.8 and 1.4 Hz, 1H), 5.1 (t, J = 9.7 Hz, 1H), 5.21
(t, J = 9.5 Hz, 1H), 5.34–5.37 (m, 1H); 13C NMR (CDCl3, 100 MHz) δ 14.1, 20.6,
20.7, 20.8, 22.7, 25.8, 25.9, 27.2, 29.3, 29.4, 29.5, 29.6, 29.7, 29.8, 31.9, 62.0, 68.5, 70.3,
71.3, 71.7, 72.9, 100.8, 129.8, 130.0, 169.3, 169.4, 170.3, 170.7; HRMS (ESI) m/z [M
+ Na]+ calcd for C32H54O10Na 621.3615, found 621.3609.
Cyclohexyl 2,3,4,6-tetra-O-acetyl-β-(D)-glucopyranoside (Table 3, Entry 7)
26
White solid; Yield 93%; Rf = 0.2 (EtOAc-Pet ether = 1:2); mp 107–109°C; [α]D
–10.57 (c = 1.02, CHCl3); 1H NMR (CDCl3, 400 MHz) δ 1.24–1.26 (m, 4H), 1.38–
1.48 (m, 2H), 1.64–1.77 (m, 3H), 1.83–1.86 (m, 1H), 1.99 (s, 3H), 2.01 (s, 3H), 2.02
(s, 3H), 2.07 (s, 3H), 3.58–3.63 (m, 1H), 3.64–3.69 (m, 1H), 4.10 (dd, J = 11.9 and
2.3 Hz, 1H), 4.25 (dd, J = 11.9 and 4.5 Hz, 1H), 4.57 (d, J = 7.8 Hz, 1H), 4.95 (dd, J
= 9.6 and 8.2 Hz, 1H), 5.07 (t, J = 9.6 Hz, 1H), 5.19 (t, J = 9.6 Hz, 1H); 13C NMR
(CDCl3, 50 MHz) δ 20.6, 20.65, 20.68, 20.7, 23.5, 23.6, 25.4, 31.5, 33.1, 62.0, 68.5,
71.4, 71.5, 72.8, 78.0, 99.3, 169.2, 169.4, 170.3, 170.7; HRMS (ESI) m/z [M + Na]+
calcd for C20H30O10Na 453.1737, found 453.1731.